Emerging Technology Partners
Overview
Emerging Technology Partners (also known as ETP Capital) is a life sciences focused investment fund with a cross border investment focus. ETP supports portfolio companies by facilitating strategic alliances including cross-border partnerships, recruiting management, and acquiring new products and technologies to accelerate growth in both US and China. ETP invests as early as the seed stage and as late as post-IPO rounds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Juventas Cell Therapy Ltd. | Nov 2020 | Series B | Co-investor |
| Human Longevity | Aug 2024 | Series B | Co-investor |
| HerAnova Lifesciences | Dec 2023 | Seed | Co-investor |
| TCRCure Biopharma | Feb 2022 | Series B | Co-investor |
| Floré | Sep 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Emerging Technology Partners based?
Emerging Technology Partners is headquartered in South San Francisco, California, United States.
When was Emerging Technology Partners founded?
Emerging Technology Partners was founded in 2000.
How many portfolio companies does Emerging Technology Partners have?
Emerging Technology Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Emerging Technology Partners's portfolio?
Portfolio companies visible on Caplight include Juventas Cell Therapy Ltd., Human Longevity, HerAnova Lifesciences, TCRCure Biopharma, Floré.
What was Emerging Technology Partners's most recent investment shown here?
Emerging Technology Partners's most recent investment in this portfolio sample was in Human Longevity in 2024.
What sectors does Emerging Technology Partners focus on?
Emerging Technology Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure.
What company stages does Emerging Technology Partners focus on?
Emerging Technology Partners typically invests at the Mid stage.
What is Emerging Technology Partners's AUM?
Emerging Technology Partners's assets under management are estimated between $100.0M and $250.0M.